CTMX

CytomX Therapeutics Inc (CTMX)

US
$ 0.6659-0.57%

Price Chart

Key Statistics

Market Cap
$ 74.85M
P/E Ratio
2.44
Revenue (TTM)
$ 138.1M
Volume
684.27K
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.10

Technicals

50-Day MA
0.6679
200-Day MA
0.9702
52 Week High
N/A
52 Week Low
N/A

About CTMX

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Employees
119
Headquarters
South San Francisco, CA
CEO
Dr. Sean A. McCarthy DPHIL

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
KDLY
Kindly MD Inc. Comm...
$ 16.05
311.46
GRYP
Gryphon Digital Min...
$ 1.56
200.96
CTMX
CytomX Therapeutics...
$ 1.80
93.87
MLGO
MicroAlgo Inc. Ordi...
$ 3.25
41.87
NXTT
Next Technology Hol...
$ 3.22
36.44

Top Losers

Symbol/Name
LTP
% Chg
ZKIN
ZK International Gr...
$ 2.88
-18.66
SATS
EchoStar Corporati...
$ 20.16
-16.63
PAAS
Pan American Silver...
$ 22.89
-15.85
WORX
SCWorx Corp. Common...
$ 0.51
-15.51
KIDZ
Classover Holdings ...
$ 4.01
-15.04